Chronic inflammation-derived nitric oxide causes conversion of human colonic adenoma cells into adenocarcinoma cells

Experimental Cell Research

Volumn 319, Issue 18, 2013, Pages 2835-2844

  Tazawa, Hiroshi ^a   Kawaguchi, Tokuichi ^b   Kobayashi, Tokushige ^c   Kuramitsu, Yasuhiro ^d   Wada, Sayori ^e   Satomi, Yoshiko ^f   Nishino, Hoyoku ^g   Kobayashi, Masanobu ^h   Kanda, Yusuke ⁱ   Osaki, Mitsuhiko ^i,j   Kitagawa, Tomoyuki ^b   Hosokawa, Masuo ^k   Okada, Futoshi ^i,j  

^a OKAYAMA UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

^c Kobayashi Dental Clinic   (Japan)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY   (Japan)

^f SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^g RITSUMEIKAN UNIVERSITY   (Japan)

^h HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

ⁱ TOTTORI UNIVERSITY   (Japan)

^j TOTTORI UNIVERSITY   (Japan)

^k Sapporo Cancer Seminar Foundation   (Japan)

more..

Author keywords

Anoikis; Chronic inflammation; Colon carcinogenesis; Human colonic adenoma cells; Nitric oxide; Three dimensional culture

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; AMINOGUANIDINE; CASPASE 3;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; ARTICLE; CANCER INCIDENCE; CARCINOMA CELL; CELL INTERACTION; CELL SURVIVAL; CHRONIC INFLAMMATION; COLON ADENOMA; COLON CARCINOGENESIS; ENZYME ACTIVATION; FAMILIAL COLON POLYPOSIS; FOREIGN BODY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR SPHEROID;

MUS MUSCULUS;

EID: 84886286889     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.08.006     Document Type: Article

References (45)

1. Burke A.J., Sullivan F.J., Giles F.J., Glynn S.A. The yin and yang of nitric oxide in cancer progression. Carcinogenesis 2013, 34:503-512.
2. Akaike T., Fujii S., Sawa T., Ihara H. Cell signaling mediated by nitrated cyclic guanine nucleotide. Nitric Oxide 2010, 23:166-174.
3. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001, 2:149-156.
4. Wink D.A., Vodovotz Y., Laval J., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998, 19:711-721.
5. Michel T., Feron O. Nitric oxide synthases: which, where, how, and why?. J. Clin. Invest. 1997, 100:2146-2152.
6. Stefanovic-Racic M., Meyers K., Meschter C., Coffey J.W., Hoffman R.A., Evans C.H. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthrit. Rheumat. 1994, 37:1062-1069.
7. Di Pasquale M., Rothstein J.L., Palazzo J.P. Pathologic features of Hashimoto's-associated papillary thyroid carcinomas. Hum. Pathol. 2001, 32:24-30.
8. Jaiswal M., LaRusso N.F., Gores G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281:G626-G634.
9. Sawa T., Ohshima H. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 2006, 14:91-100.
10. Kawanishi S., Hiraku Y., Pinlaor S., Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol. Chem. 2006, 387:365-372.
11. Rao C.V. Nitric oxide signaling in colon cancer chemoprevention. Mutat. Res. 2004, 555:107-119.
12. Takahashi M., Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci. 2004, 95:475-480.
13. Ziche M., Morbidelli L., Choudhuri R., Zhang H.T., Donnini S., Granger HJ., Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 1997, 99:2625-2634.
14. Fujii S., Sawa T., Ihara H., Tong K.I., Ida T., Okamoto T., Ahtesham A.K., Ishima Y., Motohashi H., Yamamoto M., Akaike T. The critical role of nitric oxide signaling, via protein S-guanylation and nitrated cyclic GMP, in the antioxidant adaptive response. J. Biol. Chem. 2010, 285:23970-23984.
15. Sawa T., Zaki M.H., Okamoto T., Akuta T., Tokutomi Y., Kim-Mitsuyama S., Ihara H., Kobayashi A., Yamamoto M., Fujii S., Arimoto H., Akaike T. Protein S-guanylation by the biological signal 8-nitroguanosine 3',5'-cyclic monophosphate. Nat. Chem. Biol. 2007, 3:727-735.
16. Ahn B., Ohshima H. Suppression of intestinal polyposis in Apc (Min/+) mice by inhibiting nitric oxide production. Cancer Res. 2001, 61:8357-8360.
17. Scott D.J., Hull M.A., Cartwright E.J., Lam W.K., Tisbury A., Poulsom R., Markham A.F., Bonifer C., Coletta P.L. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc (Min/+) mouse. Gastroenterology 2001, 121:889-899.
18. Rao C.V., Kawamori T., Hamid R., Reddy B.S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 1999, 20:641-644.
19. Schleiffer R., Duranton B., Gossé F., Bergmann C., Raul F. Nitric oxide synthase inhibition promotes carcinogen-induced preneoplastic changes in the colon of rats. Nitric Oxide 2000, 4:583-589.
20. Ohta T., Takahashi M., Ochiai A. Increased protein expression of both inducible nitric oxide synthase and cyclooxygenase-2 in human colon cancers. Cancer Lett. 2006, 239:246-253.
21. Hao X.P., Pretlow T.G., Rao J.S., Pretlow T.P. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients. Cancer Res. 2001, 61:419-422.
22. Seril D.N., Liao J., Yang G.Y. Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis. Mol. Carcinog. 2007, 46:341-353.
23. Kawaguchi T., Miyaki M., Masui T., Watanabe M., Ohta H., Maruyama M., Utakoji T., Kitagawa T. Establishment and characterization of an epithelial cell line with quasi-normal chromosomes from a tubular adenoma of a familial polyposis coli patient. Jpn. J. Cancer Res. 1991, 82:138-141.
24. Okada F., Kawaguchi T., Habelhah H., Kobayashi T., Tazawa H., Takeichi N., Kitagawa T., Hosokawa M. Conversion of human colonic adenoma cells to adenocarcinoma cells through inflammation in nude mice. Lab. Invest. 2000, 80:1617-1628.
25. Kobayashi H., Man S., Kapitain S.J., Teicher B.A., Kerbel R.S. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc. Nat. Acad. Sci. USA 1993, 90:3294-3298.
26. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., Klein S., Shields P.G., Billiar T.R., Harris C.C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 1998, 58:334-341.
27. Boer R., Ulrich W.R., Klein T., Mirau B., Haas S., Baur I. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol. Pharmacol. 2000, 58:1026-1034.
28. Keefer L.K., Nims R.W., Davies K.M., Wink D.A. NONOates (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 1996, 268:281-293.
29. Gallo O., Masini E., Morbidelli L., Franchi A., Fini-Storchi I., Vergari W.A., Ziche M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Nat. Cancer Inst. 1998, 90:587-596.
30. Marrogi A.J., Travis W.D., Welsh J.A., Khan M.A., Rahim H., Tazelaar H., Pairolero P., Trastek V., Jett J., Caporaso N.E., Liotta L.A., Harris C.C. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res. 2000, 6:4739-4744.
31. Wilson K.T., Fu S., Ramanujam K.S., Meltzer S.J. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998, 58:2929-2934.
32. Goto T., Haruma K., Kitadai Y., Ito M., Yoshihara M., Sumii K., Hayakawa N., Kajiyama G. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin. Cancer Res. 1999, 5:1411-1415.
33. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 1995, 72:41-44.
34. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994, 54:1352-1354.
35. Klotz T., Bloch W., Volberg C., Engelmann U., Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998, 82:1897-1903.
36. Ekmekcioglu S., Ellerhorst J., Smid C.M., Prieto V.G., Munsell M., Buzaid A.C., Grimm E.A. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin. Cancer Res. 2000, 6:4768-4775.
37. Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995, 55:727-730.
38. Itzkowitz S.H., Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G7-G17.
39. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 2002, 347:417-429.
40. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996, 111:871-885.
41. Lagares-Garcia J.A., Moore R.A., Collier B., Heggere M., Diaz F., Qian F. Nitric oxide synthase as a marker in colorectal carcinoma. Am. Surg. 2001, 67:709-713.
42. http://www.dojindo.com/store/p/237-NOC-18.aspx.
43. Simm A., Bartling B., Silber R.E. RAGE: a new pleiotropic antagonistic gene?. Ann. N.Y. Acad. Sci. 2004, 1019:228-231.
44. Kondo S., Toyokuni S., Iwasa Y., Tanaka T., Onodera H., Hiai H., Imamura M. Persistent oxidative stress in human colorectal carcinoma but not in adenoma. Free Radical Biol. Med. 1999, 27:401-410.
45. Asahi M., Fujii J., Suzuki K., Seo H.G., Kuzuya T., Hori M., Tada M., Fujii S., Taniguchi N. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J. Biol. Chem. 1995, 270:21035-21039.